share_log

Citigroup | 424B2: Prospectus

Citigroup | 424B2: Prospectus

花旗集團 | 424B2:募資說明書
美股SEC公告 ·  12/21 02:15

Moomoo AI 已提取核心訊息

Citigroup Global Markets Holdings Inc. is issuing auto-callable securities linked to CVS Health Corporation, due December 23, 2027. The securities offer quarterly contingent coupon payments at 12.25% per annum if CVS stock closes at or above the 70% coupon threshold. They feature potential early redemption and full downside exposure.The securities will be automatically redeemed if CVS stock closes at or above the initial level on any quarterly observation date from March 2025. If not called early, investors risk losing principal if CVS stock closes below the 70% barrier at maturity. The estimated initial value is $912.40 per $1,000 security, below the issue price.Wells Fargo Securities is the selling agent, receiving a 2.325% fee. The securities are subject to the credit risk of Citigroup. Investors should carefully consider the risks, including potential loss of principal, before investing.
Citigroup Global Markets Holdings Inc. is issuing auto-callable securities linked to CVS Health Corporation, due December 23, 2027. The securities offer quarterly contingent coupon payments at 12.25% per annum if CVS stock closes at or above the 70% coupon threshold. They feature potential early redemption and full downside exposure.The securities will be automatically redeemed if CVS stock closes at or above the initial level on any quarterly observation date from March 2025. If not called early, investors risk losing principal if CVS stock closes below the 70% barrier at maturity. The estimated initial value is $912.40 per $1,000 security, below the issue price.Wells Fargo Securities is the selling agent, receiving a 2.325% fee. The securities are subject to the credit risk of Citigroup. Investors should carefully consider the risks, including potential loss of principal, before investing.
花旗集團全球市場控股公司正在發行與西維斯健康公司掛鉤的自動贖回證券,到期日爲2027年12月23日。這些證券在西維斯股票收盤價達到或超過70%優惠閾值時,提供每年12.25%的季度附帶息票支付。它們具有潛在的提前贖回和全面的下行風險。如果西維斯股票在2025年3月的任何季度觀察日期收盤達到或超過初始水平,這些證券將自動贖回。如果沒有提前贖回,投資者在到期時如果西維斯股票收盤低於70%障礙,則風險會損失本金。預計初始價值爲每$1,000證券$912.40,低於發行價。富國銀行證券是銷售代理,收取2.325%的費用。這些證券受花旗集團的信用風險影響。投資者在投資前應仔細考慮風險,包括潛在的本金損失。
花旗集團全球市場控股公司正在發行與西維斯健康公司掛鉤的自動贖回證券,到期日爲2027年12月23日。這些證券在西維斯股票收盤價達到或超過70%優惠閾值時,提供每年12.25%的季度附帶息票支付。它們具有潛在的提前贖回和全面的下行風險。如果西維斯股票在2025年3月的任何季度觀察日期收盤達到或超過初始水平,這些證券將自動贖回。如果沒有提前贖回,投資者在到期時如果西維斯股票收盤低於70%障礙,則風險會損失本金。預計初始價值爲每$1,000證券$912.40,低於發行價。富國銀行證券是銷售代理,收取2.325%的費用。這些證券受花旗集團的信用風險影響。投資者在投資前應仔細考慮風險,包括潛在的本金損失。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息